Home > Our Products > Clopidogrel Tab 75mg (TGP)-100

Clopidogrel Tab 75mg (TGP)-100

Indications: It is given prophylactically as an alternative to Aspirin in patients at risk of thromboembolic disorders such as myocardial infarction, peripheral arterial disease, and stroke.

Contraindications: Clopidogrel is contraindicated in hypersensitivity, active pathological bleeding, administration within 7 days after Myocardial infarction and ischaemic stroke, coagulation disorders and lactation.

It is given by mouth as the bisulfate, but doses are expressed in terms of the base. The dose is 75mg once daily.

Clopidogrel is limited to patients at risk of increased bleeding from trauma, surgery, or other pathological conditions; ulcer; renal and hepatic impairment, history of bleeding or haemostatic disorders and pregnancy.

Dyspepsia, abdominal pain, nausea, vomiting, flatulence, constipation, gastritis, gastric and duodenal ulcers, GI upset, diarrhea, parathesia, vertigo, headache, pruritus and rashes. Potentially life-threatening adverse drug reactions: Bleeding disorders including gastrointestinal and intracranial haemorrhage. Blood dyscrasias.

Recommended Drug - Cardiovascular System - Thromboembolic Disorder Medicines
Recommended Drug - Cardiovascular System - Thromboembolic DisorderMedicines

It is given by mouth as the bisulfate, but doses are expressed in terms of the base. The dose is 75mg once daily.

Clopidogrel is limited to patients at risk of increased bleeding from trauma, surgery, or other pathological conditions; ulcer; renal and hepatic impairment, history of bleeding or haemostatic disorders and pregnancy.

Dyspepsia, abdominal pain, nausea, vomiting, flatulence, constipation, gastritis, gastric and duodenal ulcers, GI upset, diarrhea, parathesia, vertigo, headache, pruritus and rashes. Potentially life-threatening adverse drug reactions: Bleeding disorders including gastrointestinal and intracranial haemorrhage. Blood dyscrasias.

Scroll to Top